Cover Image

Conversion to generic cyclosporine A in stable chronic patients after heart transplantation

Maximilian Kraeuter,1 Matthias Helmschrott,1 Christian Erbel,1 Christian A Gleissner,1 Lutz Frankenstein,1 Bastian Schmack,2 Arjang Ruhparwar,2 Philipp Ehlermann,1 Hugo A Katus,1 Andreas O Doesch1 1Department of Cardiology, 2Department of Cardiac Surgery, University of Heidelberg, Heidelberg, German...

Full description

Saved in:

Bibliographic Details
Main Authors:	Kraeuter M (Author), Helmschrott M (Author), Erbel C (Author), Gleissner CA (Author), Frankenstein L (Author), Schmack B (Author), Ruhparwar A (Author), Ehlermann P (Author), Katus HA (Author), Doesch AO (Author)
Format:	Book
Published:	Dove Medical Press, 2013-11-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Advantageous effects of immunosuppression with tacrolimus in comparison with cyclosporine A regarding renal function in patients after heart transplantation
by: Helmschrott M, et al.
Published: (2015)

Long-term use of amiodarone before heart transplantation significantly reduces early post-transplant atrial fibrillation and is not associated with increased mortality after heart transplantation
by: Rivinius R, et al.
Published: (2016)

Superior rejection profile during the first 24 months after heart transplantation under tacrolimus as baseline immunosuppressive regimen
by: Helmschrott M, et al.
Published: (2014)

Analysis of malignancies in patients after heart transplantation with subsequent immunosuppressive therapy
by: Rivinius R, et al.
Published: (2014)

Effects of vildagliptin (Galvus®) therapy in patients with type 2 diabetes mellitus after heart transplantation
by: Gueler I, et al.
Published: (2013)

Heart rate reduction for 36 months with ivabradine reduces left ventricular mass in cardiac allograft recipients: a long-term follow-up study
by: Doesch AO, et al.
Published: (2013)

The influence of surgical technique on early posttransplant atrial fibrillation — comparison of biatrial, bicaval, and total orthotopic heart transplantation
by: Rivinius R, et al.
Published: (2017)

Effects of oral valganciclovir prophylaxis for cytomegalovirus infection in heart transplant patients
by: Doesch AO, et al.
Published: (2012)

Increased adherence eight months after switch from twice daily calcineurin inhibitor based treatment to once daily modified released tacrolimus in heart transplantation
by: Doesch AO, et al.
Published: (2013)

Chronic digitalis therapy in patients before heart transplantation is an independent risk factor for increased posttransplant mortality
by: Rivinius R, et al.
Published: (2017)

Comparison of posttransplant outcomes in patients with no, acute, or chronic amiodarone use before heart transplantation
by: Rivinius R, et al.
Published: (2017)

Renal function in heart transplant patients after switch to combined mammalian target of rapamycin inhibitor and calcineurin inhibitor therapy
by: Helmschrott M, et al.
Published: (2017)

CCL19 and CCL21 modulate the inflammatory milieu in atherosclerotic lesions
by: Akhavanpoor M, et al.
Published: (2014)

Inhibition of B7-1 (CD80) by RhuDex® reduces lipopolysaccharide-mediated inflammation in human atherosclerotic lesions
by: Doesch AO, et al.
Published: (2014)

Therapeutic monitoring of pediatric transplant patients with conversion to generic tacrolimus
by: Natalia Riva, et al.
Published: (2017)

OF THE APPLICATION OF THE CYCLOSPORINE GENERICS IN THE PEDIATRIC RHEUMATOLOGY
by: S.I. Valieva, et al.
Published: (2007)

OF THE APPLICATION OF THE CYCLOSPORINE GENERICS IN THE PEDIATRIC RHEUMATOLOGY
by: S.I. Valieva, et al.
Published: (2007)

Budget impact analysis of conversion from cyclosporine to sirolimus as immunosuppressive medication in renal transplantation therapy
by: Foroutan N, et al.
Published: (2013)

Efficacy and safety of a conversion from the original tacrolimus and mycophenolate mofetil to the generics Tacpan® and Mowel® after liver transplantation
by: Vollmar J, et al.
Published: (2015)

Pretransplant assessment of cyclosporine level as a predictor of cyclosporine dose requirements after kidney transplantation
by: Sahier O El-Khashab, et al.
Published: (2019)

CYCLOSPORINE-INDUCED GINGIVAL OVERGROWTH IN RENAL TRANSPLANT RECIPIENTS
by: Ana Maria Filioreanu, et al.
Published: (2018)

Pharmacokinetics of apixaban and tacrolimus or cyclosporine in kidney and lung transplant recipients
by: Holly Mansell, et al.
Published: (2022)

Cyclosporine versus tacrolimus: cost-effectiveness analysis for renal transplantation in Brazil
by: Augusto Afonso Guerra Júnior, et al.
Published: (2015)

Colchicine-induced myoneuropathy in a cyclosporine-treated renal transplant recipient
by: Kyungmin Huh, et al.
Published: (2013)

Effect of cyclosporine therapy in transplanted patients-diagnostic values of tubular markers
by: Todor Gruev, et al.
Published: (2003)

STUDY OF CLINICAL EFFICACY OF ORIGINAL AND GENERIC DRUGS OF IVABRADINE IN PATIENTS WITH STABLE ANGINA (СOMPARATIVE STUDY)
by: S. V. Povetkin, et al.
Published: (2018)

Increasing the Conversion of Hyoscyamine to Scopolamine in Stable Autotetraploid Plants of Egyptian Henbane (Hyoscyamus muticus)
by: E Dehghan, et al.
Published: (2012)

Effect of Cyclosporine on the Relevant Biochemical Parameters in Renal Transplantation Patients in Mosul/Iraq
by: Suad Alkass, et al.
Published: (2013)

Efficacy and safety of febuxostat in the treatment of hyperuricemia in stable kidney transplant recipients
by: Sofue T, et al.
Published: (2014)

Immunosuppression with Generics in Liver and Kidney Transplantation: A Real-World Evidence Study
by: Finocchietti M, et al.
Published: (2024)

Cyclosporine
by: Nahide Onsun
Published: (2022)

Transforming growth factor-β profile in cyclosporine-A induced gingival enlargement in renal transplant patients
by: Azza A. Abushama, et al.
Published: (2021)

Multiple Eruptive Sebaceous Hyperplasia Secondary to Cyclosporin in a Patient with Bone Marrow Transplantation
by: Begonia Cortés, et al.
Published: (2016)

Early non-steady-state population pharmacokinetics of oral cyclosporine in renal transplant recipients
by: Baek H, et al.
Published: (2014)

Tp-e interval and Tp-e/QT ratio in clinically stable pediatric heart transplant recipients
by: Serhat Koca, et al.
Published: (2019)

A survey on the effects of Azithromycin in the treatment of gingival overgrowth induced by Cyclosporin in renal transplant patients
by: Kadkhoda Z., et al.
Published: (2004)

Association Between Blood and Lymphocyte Levels of Cyclosporin A and Infectious Complications in Renal Transplant Patients
by: Aline Milane, et al.
Published: (2021)

Cyclosporine A-related neurotoxicity after haploidentical hematopoietic stem cell transplantation in children with hematopathy
by: Yong Wang, et al.
Published: (2021)

Nephro and neurotoxicity of calcineurin inhibitors and mechanisms of rejections: A review on tacrolimus and cyclosporin in organ transplantation
by: Zahra Tolou-Ghamari
Published: (2012)

Amniotic Membrane as a Scaffold for Melanocyte Transplantation in Patients with Stable Vitiligo
by: Pedro Redondo, et al.
Published: (2011)